ArticlePharmaceuticals (Basel, Switzerland)2022

Oncostatin M Receptor as a Therapeutic Target for Radioimmune Therapy in Synovial Sarcoma.

Sarah McCollum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.